43.00
price down icon0.72%   -0.31
after-market Dopo l'orario di chiusura: 42.90 -0.10 -0.23%
loading

Boston Scientific Corp Azioni (BSX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
4.59%
5,442.00
5,203.00 5,286.00 5,065.00 5,061.00
Cost Of Revenue
0.25%
1,594.00
1,590.00 1,608.00 1,523.00 1,637.00
Gross Profit
6.47%
3,848.00
3,614.00 3,679.00 3,542.00 3,424.00
Operating Expenses
6.25%
2,670.00
2,513.00 2,854.00 2,494.00 2,605.00
Interest Income/Expense
6.67%
96.00
90.00 90.00 87.00 90.00
Operating Income/Loss
6.99%
1,178.00
1,101.00 825.00 1,048.00 819.00
Income/Loss From Continuing Operations Before Tax
8.78%
1,060.00
1,162.00 700.00 939.00 941.00
Income Tax Expense/Benefit
188.07%
155.00
-176.00 30.00 183.00 146.00
Net Income/Loss
32.41%
905.00
1,339.00 670.00 755.00 795.00
Attributable To Noncontrolling Interest
0.00%
-2.00
-2.00 -2.00 - -2.00
Basic Average Shares
0.99%
1,470.20
1,484.90 0.80 1,481.70 1,479.90
Diluted Average Shares
1.35%
1,474.80
1,495.00 0.50 1,495.50 1,493.50
Basic Earnings Per Share
31.11%
0.62
0.90 0.46 0.51 0.54
Diluted Earnings Per Share
32.22%
0.61
0.90 0.45 0.51 0.53
EW EW
$86.45
price up icon 1.38%
$83.47
price down icon 1.87%
$68.47
price down icon 0.47%
PHG PHG
$25.00
price up icon 0.44%
STE STE
$217.26
price down icon 0.23%
ZBH ZBH
$91.77
price down icon 0.34%
Capitalizzazione:     |  Volume (24 ore):